ArticleTransplantation and cellular therapy2026
Post-transplant Cyclophosphamide (PTCy) for HLA-Matched Hematopoietic Stem Cell Transplant (HCT) in Pediatric and Young Adult Patients with Hematologic Malignancies.
Megan M Murphy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.